Ergomed Liabilities 2024

Ergomed Aktienanalyse

What does Ergomed do?

Ergomed PLC is a company specialized in clinical research, based in the UK since 1997. It specializes in supporting biotech and pharmaceutical companies in conducting clinical phase studies and post-marketing surveillance. Ergomed is listed on the London Stock Exchange and has offices in Europe and the USA. The company was originally founded as Ergomed Clinical Research Limited by physician Miroslav Reljanovic, who recognized the lack of resources for small biotech companies to conduct their own clinical studies. Ergomed offers a range of services tailored to the needs of biotech and pharmaceutical companies, including clinical research services, medical information and pharmacovigilance services, and regulatory affairs. It also provides venture capital investments for selected biotech companies. Ergomed offers comprehensive clinical research services, including study planning, trial management, and study monitoring. It also has expertise in data management and statistics to ensure accurate results. The company provides medical information to inform patients and healthcare professionals and offers support for drug monitoring during and after approval. Ergomed also supports companies in submitting regulatory applications and addressing regulatory questions. It has extensive experience working with national, European, and global regulatory authorities to ensure drug approval and compliance. Ergomed does not offer its own products but provides services to biotech and pharmaceutical companies. It collaborates with various companies to conduct clinical trials and develop drugs. In conclusion, Ergomed is a specialized company in clinical research that offers a wide range of services to biotech and pharmaceutical companies. It specializes in supporting them in conducting clinical phase studies and post-marketing surveillance. Ergomed has extensive experience working with regulatory authorities at national, European, and global levels to ensure drug approval and compliance. Ergomed ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Ergomed's Liabilities

Ergomed's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Ergomed's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Ergomed's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Ergomed's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Ergomed’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Ergomed stock

What is the level of liabilities of Ergomed this year?

Ergomed has a debt balance of 44.6 M GBP this year.

What were the liabilities of Ergomed compared to the previous year?

The liabilities of Ergomed have increased by 15.09% increased compared to the previous year.

What are the consequences of high debt for investors of Ergomed?

High liabilities can pose a risk for investors of Ergomed, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Ergomed?

Low liabilities mean that Ergomed has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Ergomed affect the company?

An increase in liabilities of Ergomed can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Ergomed affect the company?

A decrease in the liabilities of Ergomed can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Ergomed?

Some factors that can influence the liabilities of Ergomed include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Ergomed so important for investors?

The liabilities of Ergomed are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Ergomed take to modify the liabilities?

To change its liabilities, Ergomed can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Ergomed pay?

Over the past 12 months, Ergomed paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ergomed is expected to pay a dividend of 0 GBP.

What is the dividend yield of Ergomed?

The current dividend yield of Ergomed is .

When does Ergomed pay dividends?

Ergomed pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ergomed?

Ergomed paid dividends every year for the past 0 years.

What is the dividend of Ergomed?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ergomed located?

Ergomed is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ergomed kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ergomed from 9/13/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Ergomed pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Ergomed in the year 2023?

In the year 2023, Ergomed distributed 0 GBP as dividends.

In which currency does Ergomed pay out the dividend?

The dividends of Ergomed are distributed in GBP.